Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma

Background Although endometrial adenocarcinoma is a common gynaecological cancer, a comparatively small proportion of patients present with, or develop, recurrent or advanced disease. However, for those women whose disease does progress or recur the prognosis is poor and the best treatment is yet to be identified. Co‐morbidity, including obesity and cardiac disease, and concerns over toxicity have prevented more extensive studies of cytotoxic...